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Kesan Anti-diabetes dan Pankreatoprotektif Madu Kelulut keatas Model Tikus 






Madu kelulut (SLBH) berasal dari spesis lebah kelulut daripada 
Geniotrigona thoracica (G. thoracica), telah didakwa mempunyai kesan anti- 
diabetes. Walau bagaimanapun, tidak ada bukti saintifik untuk mengesahkan 
tuntutan ini. Tambahan pula, mekanisme yang mendasari kesan anti-diabetes madu 
ini tidak diketahui (jika ada). Dalam kajian ini, kesan SLBH pada parameter 
metabolik iaitu glukosa darah berpuasa (FBG), profil lipid, insulin, berat badan, 
pengambilan makanan dan air telah disiasat. Kesan pengambilan SLBH pada 
pankreas morfologi, histopatologi, tekanan oksidatif, keradangan dan apoptosis turut 
disiasat. Keputusan kajian menunjukkan bahawa pemberian SLBH selama 28 hari 
pada dos 1 dan 2 g berat badan menghalang kenaikan FBG, kolesterol total, 
trigliserida dan kolesterol LDL dan penurunan paras HDL-kolesterol dan insulin. 
Pemberian SLBH juga mengurangkan perubahan histopatologi di dalam islet 
pankreas dan memelihara morfologi pankreas dan islet pankreas hampir normal. 
Sementara itu, peningkatan dalam tekanan oksidatif, keradangan dan apoptosis 
dalam tikus diabetik telah dikurangkan berikutan pemberian 28-hari SLBH. Kesan 
SLBH didapati bergantung kepada dos. Kesan 2 g berat badan SLBH didapati 
hampir sama dengan kesan glibenclamide (kawalan positif). Kesimpulannya, SLBH 






Anti-diabetic and Pancreatoprotective Effects of Stingless Bee Honey in 






Stingless bee honey (SLBH) is produced by a stingless bee species namely 
Geniotrigona thoracica (G. thoracica). Honey has been claimed to have anti- 
diabetic effects. However, there has been no scientific proof to validate this claim  
for SLBH. In addition, the mechanisms underlying the anti-diabetic effect (if any) of 
this honey has not been reported previously. In the current study, the effect of SLBH 
on biochemical and biological parameters such as fasting blood glucose (FBG), lipid 
profiles, insulin, body weight, food and water intake were investigated. Effects of 
SLBH consumption on pancreas morphology, histopathology, oxidative stress, 
inflammation and apoptosis were also investigated. The findings indicated that 28- 
days oral administration of SLBH at 1 and 2 g/kg body weight have prevented the 
increase in FBG, total cholesterols, triglyceride and LDL cholesterol and the 
decrease in HDL-cholesterol and insulin levels. Administration of SLBH also has 
ameliorated histopathological changes in the pancreatic islets and preserved the 
morphology of the pancreas and pancreatic islets to a near normal condition. 
Meanwhile, increased oxidative stress, inflammation and apoptosis in diabetic rats’ 
pancreas were ameliorated following 28-days administration of SLBH. SLBH was 
found to display a dose-dependent effectiveness. Effects of 2 g/kg body weight 
SLBH was found to be almost identical to the effects exerted by glibenclamide 












1.1 Research Background 
 
 
In the recent years, the increasing prevalence of diabetes globally has led 
to extensive research with regards to its treatment. The mechanisms 
underlying diabetes treatment, with regards to the effect of herbs and a large 
variety of natural products as a functional food have been claimed to 
ameliorate diabetes progression and complications however remains largely 
unexplored (Scheen, 2014). 
Glycemic regulation is centralized within the β-cells of the pancreatic 
islets of Langerhans where the insulin production and secretion takes place 
(Pagliuca et al., 2014). Type 1 diabetes mellitus is due to insulin deficiency 
due to failure of the pancreas to produce insulin whereas Type 2 diabetes 
relates to the event of insulin resistance in which insulin receptors and insulin 
receptor substrates are damaged or disrupted. These contributes to the 
obstruction of the insulin signaling pathway leading to metabolic 
complications (Withers et al., 1998). In hyperglycemia, the oxidative stress 
levels in the tissues are increased. Levels of tissue anti-oxidative enzymes are 




in ROS also cause tissue histopathological changes which ultimately may 
result in multiple organ damage (Francis & Sudha, 2016). 
Besides the standard anti-diabetic medications such as sulfonylureas, 
biguanides, thiazolidinediones (glitazones), α-glucosidase inhibitors, and 
meglitinides which are normally prescribed to patients with diabetes which 
focuses on lowering the blood glucose level, large number of alternative 
treatments from natural resources are available to treat diabetes (Adam et al., 
2016; Adewole & Caxton-Martins, 2006; Eteraf-Oskouei & Najafi, 2013). 
These ranges from plant extracts, vinegars, and honey. Controversially, 
despite containing glucose, honey has been found to be a powerful source of 
antioxidant which protects the organs against oxidative damage. Diabetes 
patients have been reported to display high glucose tolerance following 
honey consumption (Al-Waili, 2004). The uniqueness of honey not only rely 
on its capability to neutralize the ROS, but also its capability to improve 
insulin response towards glucose. Few theories suggest that the content of 
reducing sugar in honey might be one of the reasons for its effectiveness in 
diabetes treatment (Erejuwa et al., 2010). 
Stingless bee honey availability varies according to the topographical and 
geographical locations. Different types of bees have their own honey quality. 
Based on the bee species, honey can generally be divided into two types 
which are honey bee honey and stingless honey bees (SLBH). Stingless bee 




the conventional honey bee and the honey derived from these bees have been 
reported to be rich in flavonoids, polyphenolics, , vitamins, etc. (Bertoncelj et 
al., 2007). The two most common stingless bees cultured by the farmers in 
peninsular Malaysia are Heterotrigona itama and Geniotrigona thoracica 
(Kelly et al., 2014). These two bees are known for their good quality honey 
among the farmers. 
Recent reports on the medical benefits of SLBH mostly related to its 
physicochemical, antimicrobial and radical scavenging activities. In the 
current study, the anti-hyperglycemic effects of G. thoracica SLBH were 
investigated in streptozotocin (STZ)-nicotinamide induced diabetic rat  
model. Further, this study aimed to elucidate the mechanisms underlying the 






Administration of G. thoracica SLBH could ameliorate the metabolic 
changes in diabetes and reduces histopathological changes in the pancreas. 
Additionally, SLBH administration could help to reduce oxidative stress, 







The objectives of this study are: 
 
 
1. To determine the efficacy of SLBH on body weight, water and 
food intake in the experimental groups. 
 
 
2. To determine the changes in fasting blood glucose, serum insulin 
and serum lipid profiles in the experimental groups. 
 
 
3. To elucidate the mechanism of action of SLBH on morphology 
changes in the pancreas in the experimental groups. 
 
 
4. To investigate the efficacy of SLBH on the alterations in oxidative 











2.1 Geniotrigona thoracica: The Stingless Bee 
 
 
In the recent years, the health benefits of stingless bee honey has gained 
much attention from the nutritionist community. This has led to the rising 
number of scientific reports which has documented the beneficial effects of 
stingless bee honey on health and lifestyle in various aspects. As of now, 
meliponini stingless bees have been identified and classified from various 
tropical and subtropical regions in the world into 23 genera and 18 sub- 
genera with a rough estimation of around several hundred different species 
and the number is still increasing (Michener, 2000). 
In the current study, stingless bee honey is selected from the species 
Geniotrigona thoracica. One of the reasons for this selection is because the 
honey from this species is one of the two most sought after SLBH in 
Malaysia by meliponiculturists (Kek et al., 2016). Although this species has 
been widely known among entomologists and meliponiculturists, there have 
not been many studies conducted on the honey produced by G. thoracica 




hyperglycemic effect of honey were obtained from other type of honey 
(Erejuwa et al., 2010). 
G. thoracica is a non-aggressive type of stingless bee, evidence from 
their non-aggressive approach in colony and nest defense (Roubik, 2006). 
One of the most distinguished characteristics of G. thoracica nest is that it 
has a very wide, enormous openings created by the bees that functions as 
entrance to the hive. Resin is essentially present at the entrance of the hive as 
the way to identify their own nest. 
The honey produced by G. thoracica is not essentially sweet in nature. 
Their taste may vary according to the regional season. The taste of the honey 
is dependent on the availability of the resources which corresponds to the 
flower seasons, monsoon and floral abundance in the perimeter where the  
bee lives (Salim et al., 2012). As G. thoracica SLBH is not a monofloral 
honey, its honey quality and content varies by the change of climate or other 
environmental changes such as change of season or human deforestation 
activity. Figure 2.1 shows the morphology of the stingless bee as observed 
from (A) lateral view and (B) dorsal view. Image (C) shows the hive’s 
entrance and image (D) shows the honeypots. Figure 2.2 shows the regions  






Figure 2.1: (A) lateral view (B) dorsal view (C) hive entrance and (D) honey pots of 
G. thoracica stingless bee. 
Figure 2.2: Distribution of stingless bee in different parts of the world 




2.2 Types of honeys and their compositions 
 
 
Traditional practices using honey for its benefits has attracted scientists 
to conduct studies to unveil the underlying mechanisms involved. Since then, 
a wide range of studies have been performed in various respective fields 
aiming to solve the current issues with regards to the use of honey in 
medicine. Other than herbal extracts, honeys are also classified as a natural 
product. Honey is produced by bees using resources from plants. Generally 
stingless bees harvest the pollen and nectar from multiple types of plants 
(polyfloral) according to the availability while others are selectively 
harvesting from a single type of plant (monofloral). Therefore honeys differ 
according to the preferred plant or the location by the bees (Rao et al., 2016). 
Entomologists called some honeys by their genus or species. The importance 
of honey nomenclature lies within their content, which sets every honey type 
differ from each other. This was of classification could also provide a more 
convenient way to address types of honeys according to their uses. Table 2.1 
lists the reported compositions of various types of honey from different parts 




Table 2.1: Various reported compositions of honey. 
 
Type of Honey Reported Compositions Reference 
 
Sourwood honey 
Fructose, glucose, maltose, sucrose, 
oligosaccharides, ash, amino acids, 
proteins, acids 
 
(Shin & Ustunol, 2005) 
 
Alfalfa honey 
Fructose, glucose, maltose, sucrose, 
oligosaccharides, ash, amino acids, 
proteins, acids 
 
(Shin & Ustunol, 2005) 
 
Sage honey 
Fructose, glucose, maltose, sucrose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, proteins, acids 
 





Fructose, glucose, maltose, sucrose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, proteins, acids, 
gallic acid, syringic acid, benzoic acid, 
trans-cinnamic acid, p-coumaric acid, 
and caffeic acids, catechin, 




(Chua et al., 2012) 







Fructose, glucose, maltose, sucrose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, proteins, acids, 
gallic acid, syringic acid, benzoic acid, 
trans-cinnamic acid, p-coumaric acid, 
and caffeic acids, catechin, 






(Chua et al., 2012) 









Fructose, glucose, maltose, sucrose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, proteins, acids, 
gallic acid, syringic acid, benzoic acid, 
trans-cinnamic acid, p-coumaric acid, 
and caffeic acids, catechin, 

















Fructose, glucose, maltose, sucrose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, proteins, acids, 
gallic acid, syringic acid, benzoic acid, 
trans-cinnamic acid, p-coumaric acid, 
and caffeic acids, catechin, 









Fructose, glucose, sucrose, meletizose, 
erlose, trehalose, turanose, panose, 1- 
kestose, 6-kestose, palatinose, 
meletizose, reffinose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, proteins 
 
 




Fructose, glucose, sucrose, meletizose, 
erlose, trehalose, turanose, panose, 1- 
kestose, 6-kestose, palatinose, 
meletizose, reffinose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, proteins 
 
 




Fructose, glucose, sucrose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, proteins, 
sodium, magnesium, aluminum, 
potassium, calcium, chromium, 
manganese, cobalt, nickel, zinc, 
rubidium, strontium, barium, lead 
 
 




Fructose, glucose, sucrose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, proteins, 
sodium, magnesium, aluminum, 
potassium, calcium, chromium, 
manganese, cobalt, nickel, zinc, 
rubidium, strontium, barium, lead 
 
 




Fructose, glucose, sucrose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, proteins, 
sodium, magnesium, aluminum, 
potassium, calcium, chromium, 
manganese, cobalt, nickel, zinc, 
rubidium, strontium, barium, lead 
 
 









Fructose, glucose, sucrose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, proteins, 
sodium, magnesium, aluminum, 
potassium, calcium, chromium, 
manganese, cobalt, nickel, zinc, 
rubidium, strontium, barium, lead 
 
 







Fructose, glucose, sucrose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, irons, proteins, 
ascorbic acid, catalase, peroxidase, 
carotenoids, caffeic acids, coumaric 
acids, ferrulic acids, ellagic acids, 
chlorogenic acids, chrysin, 
pinocembrin, pinobanksin, quercetin, 
kaempferol, luteolin, galangin, 














Fructose, glucose, sucrose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, irons, proteins, 
ascorbic acid, catalase, peroxidase, 
carotenoids, caffeic acids, coumaric 
acids, ferrulic acids, ellagic acids, 
chlorogenic acids, chrysin, 
pinocembrin, pinobanksin, quercetin, 
kaempferol, luteolin, galangin, 













Fructose, glucose, sucrose, 
oligosaccharides, ash, potassium, 
sodium, amino acids, irons, proteins, 
ascorbic acid, catalase, peroxidase, 
carotenoids, caffeic acids, coumaric 
acids, ferrulic acids, ellagic acids, 
chlorogenic acids, chrysin, 
pinocembrin, pinobanksin, quercetin, 
kaempferol, luteolin, galangin, 





(Bertoncelj et al., 2007) 
12  
 
